There are numerous studies in the general population and among patients with chronic kidney disease that show glucagon-like peptide-1 (GLP-1) medications are safe and effective for weight loss. Formed in March 2024, the Comprehensive Transplant Centers kidney transplant weight loss program uses a combination of diet, exercise, counseling and weight loss injection medication to help patients reach weight loss goals to make them eligible for transplantation
36 HmbelinM.GriesserV.KellerT.SchurterW.HaikerM.HohmannH
The food noise that is dampened while on GLP-1s likely returns after stopping use, increasing the importance of dietary levers to induce satiety
The most common side effects of Zepbound may include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, and hair loss, especially when starting the medication or after a dose increase
Summaries are presented for each rewarding category below
No major side effects when taken as recommended